Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
Sarepta Therapeutics, Inc. reported a 0% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13D/A)
Event Aug 13, 2025 · Filed Aug 15, 2025
Sarepta Therapeutics, Inc. reported a 0% stake in Arrowhead Pharmaceuticals, Inc., 0 shares, with active intent on Aug 13, 2025. Filed Aug 15, 2025 (Schedule 13D/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sarepta Therapeutics, Inc. | 0% | 0 |
| Sarepta Therapeutics Investments, Inc. | 0% | 0 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- Sarepta Therapeutics, Inc.
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13D · Sarepta Therapeutics, Inc. · Feb 14, 2025
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026